New Delhi [India], January 5 (ANI): The precautionary COVID-19 vaccine dose, which is to be given to healthcare and frontline workers, and those over 60 years of age with co-morbidities from January 10, will be the same vaccine as administered previously in the first two doses, said Dr VK Pa
New Delhi [India], December 2 (ANI): The Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country, officials informed ANI on Thursday.
Pune (Maharashtra) [India], October 1 (ANI): Serum Institute of India (SII) has supplied 78 crore doses of its COVID-19 vaccine Covishield so far and its target is to supply almost 21.50 crore doses in the month of October, informed the sources to ANI on Friday.
Rome [Italy], September 24 (ANI): Italy recognised India's COVID-19 vaccine "Covishield" on Friday, said the Embassy of India in Italy. After the move, Indian vaccine cardholders are now eligible for Green Pass in the European country.
Kochi (Kerala) [India], September 23 (ANI): The Central government on Wednesday submitted an appeal before the Kerala High Court seeking to quash a High Court Single Bench's order directing it to make provisions on the Cowin portal to enable those who are keen to take the second dose of Covi
Kochi (Kerala) [India], September 6 (ANI): The Kerala High Court on Monday allowed Kitex Garments Ltd company to administer the second dose of Covishield vaccine to its workers before the completion of an 84-day gap of first dose.
Kochi (Kerala) [India], September 3 (ANI): The Central government has submitted in the Kerala High Court on Friday that the duration of 84 days between 1st and 2nd doses of Covishield vaccine is providing the best protection against COVID-19.
New Delhi [India], August 8 (ANI): The Indian Council of Medical Research (ICMR) has revealed in its study that the combination of Covaxin and Covishield vaccines, the two main vaccines of the COVID-19 vaccination programme, conducted on 18 people, has elicited better safety and immunogen
New Delhi [India], August 6 (ANI): In order to ramp up COVID-19 vaccine supply in the country, Union Health Minister Mansukh Mandaviya on Friday met Serum Institute of India (SII) CEO Adar Poonawalla in the national capital and held a discussion over the supply of Covishield vaccine.
New Delhi [India], July 22 (ANI): The Delhi government on Thursday said that doses of the Covishield coronavirus vaccine will be reserved only for those eligible for the second dose with immediate effect till July 31 due to its limited supply.
Geneva [Switzerland], July 10 (ANI): World Health Organisation (WHO) chief scientist Soumya Swaminathan on Friday said 15 countries in the European Union (EU) now recognise Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University
New Delhi [India], July 9 (ANI): Charge d'affaires of Belgium Embassy Arnaud Lion on Friday said that recognition of Covishield by his country will have a positive impact for everyone getting the vaccine shot in India and abroad.